BETHESDA, Md.--(BUSINESS WIRE)--Jan. 6, 2006--Cangen Biotechnologies, Inc. today announced the expansion of its ongoing research collaboration with Olympus Corporation, initiated in May 2005, to develop a hybrid DNA-based and protein-based diagnostic test for use in the early detection of lung cancer. The expanded collaboration includes funding for a prospective clinical study.
